← All organizations
Highest phase reached
Phase 1
First clinical trial
Jul 23, 2018Last known activity
May 16, 2019
Acquired by Alkermes on Nov 28, 2019
Timeline
2010s
- Jun 1, 2013
Rodin Therapeutics— Founded
- Nov 28, 2019
Alkermes— Acquired By
Drugs by trial phase (2 distinct, 3 trials)
Indications
Studied for
Recent trials (3)
- NCT03963973Lead sponsorPhase 1May 16, 2019
- NCT03668314Lead sponsorPhase 1Oct 10, 2018
- NCT03577262Lead sponsorEarly Phase 1Jul 23, 2018
Details
- Founded
- Cambridge, MA, US Jun 1, 2013
- Last known activity
- May 16, 2019